Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 15/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | TP53 | P04637 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19650689 | 0.93 | THRB (0.45) | THRBESR1ESR2MAPTSMN1; SMN2 | |
| SCHEMBL2230807 | 0.93 | THRB (0.48) | THRBESR1ESR2PDK2MAPT | |
| SCHEMBL16551559 | 0.93 | THRB (0.48) | THRBESR1ESR2PDK2MAPT | |
| SCHEMBL19651947 | 0.89 | THRB (0.42) | THRBMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL16903532 | 0.88 | THRB (0.43) | THRBESR1ESR2PDK2ALDH1A1 | |
| SCHEMBL16903538 | 0.87 | THRB (0.46) | THRBPDK2 | |
| SCHEMBL16903525 | 0.85 | THRB (0.54) | THRBPDK2MAPTSMN1; SMN2 | |
| SCHEMBL24478129 | 0.83 | THRB (0.51) | THRBPDK2MAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL16903527 | 0.83 | THRB (0.48) | THRBPDK2ALDH1A1 | |
| SCHEMBL24477930 | 0.83 | THRB (0.51) | THRBPDK2MAPTSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220169766-A1 | CURABLE COMPOSITION, CURED SUBSTANCE, OPTICAL MEMBER, AND LENS | FUJIFILM CORPORATION (JP) | 2022-06-02 | — | — | US | disclosed |
| US-11230619-B2 | Curable composition, cured product, optical member, lens, and method for producing cured product | FUJIFILM CORPORATION (JP) | 2022-01-25 | — | — | US | disclosed |
| US-20190233563-A1 | CURABLE COMPOSITION, CURED PRODUCT, OPTICAL MEMBER, LENS, AND METHOD FOR PRODUCING CURED PRODUCT | FUJIFILM CORPORATION (JP) | 2019-08-01 | — | — | US | disclosed |
| US-9334352-B2 | Semi-cured product, cured product and method for producing these, optical component, curable resin composition, and compound | FUJIFILM CORPORATION (JP) | 2016-05-10 | — | — | US | disclosed |
| US-9334352-B2 | Semi-cured product, cured product and method for producing these, optical component, curable resin composition, and compound | FUJIFILM CORPORATION (JP) | 2016-05-10 | — | — | US | disclosed |
| US-20150197592-A1 | SEMI-CURED PRODUCT, CURED PRODUCT AND METHOD FOR PRODUCING THESE, OPTICAL COMPONENT, CURABLE RESIN COMPOSITION, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2015-07-16 | — | — | US | disclosed |
| US-20150197592-A1 | SEMI-CURED PRODUCT, CURED PRODUCT AND METHOD FOR PRODUCING THESE, OPTICAL COMPONENT, CURABLE RESIN COMPOSITION, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2015-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150197592-A1 | SEMI-CURED PRODUCT, CURED PRODUCT AND METHOD FOR PRODUCING THESE, OPTICAL COMPONENT, CURABLE RESIN COMPOSITION, AND COMPOUND | RER1, DCXR, PSME4 | THRB 3399/4885ESR1 1795/4885ESR2 1601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.